Literature DB >> 15534516

Mid-term to long-term followup of two-stage reimplantation for infected total knee arthroplasty.

Abdul A Haleem, Daniel J Berry, Arlen D Hanssen.   

Abstract

Between January 1989 and December 1994, 94 patients (96 knees) had a two-stage reimplantation for treatment of an infected total knee arthroplasty. All patients were treated with an interval antibiotic-loaded static cement spacer and had antibiotic-loaded bone cement for prosthesis fixation at the time of reimplantation. The purpose of this study was to assess the long-term risk of reinfection and the mechanical durability of these reimplantation arthroplasties. Patients were followed up for a median of 7.2 years (range, 2.5-13.2 years). At final followup, 15 knees (16%) had required reoperation. Nine knees (9%) had component removal for reinfection and six knees (6%) were revised for aseptic loosening. The median time to reoperation for reinfection was 1 year (range, 0.1-9.8 years). The risk of recurrent infection was not correlated with the type of organism, patient demographics, or method of prosthesis fixation at reimplantation. The survivorship free of implant removal for any reason was 90% (confidence intervals, 83.9-96.4%) at 5 years and 77.3% (confidence intervals, 65.5-89.6%) at 10 years. The survivorship free of implant removal for reinfection was 93.5% (confidence intervals, 88.5-98.7%) at 5 years and 85% (confidence intervals, 73.8-96.3%) at 10 years. Survival free of revision for mechanical failure (aseptic loosening or radiographic loosening) was 96.2% (confidence intervals, 92-100%) at 5 years and 91% (confidence intervals, 80.8-98.3%) at 10 years. These results suggest that the high likelihood of early success after two-stage reimplantation of an infected TKA is well maintained throughout long-term followup, with a modest rate of late recurrent infection or mechanical implant failure.

Entities:  

Mesh:

Year:  2004        PMID: 15534516     DOI: 10.1097/01.blo.0000147713.64235.73

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  74 in total

1.  High rate of infection control with one-stage revision of septic knee prostheses excluding MRSA and MRSE.

Authors:  Joachim Singer; Andreas Merz; Lars Frommelt; Bernd Fink
Journal:  Clin Orthop Relat Res       Date:  2011-11-12       Impact factor: 4.176

Review 2.  Two-stage revision of septic knee prosthesis with articulating knee spacers yields better infection eradication rate than one-stage or two-stage revision with static spacers.

Authors:  C L Romanò; L Gala; N Logoluso; D Romanò; L Drago
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-01-21       Impact factor: 4.342

3.  Intraoperative molds to create an articulating spacer for the infected knee arthroplasty.

Authors:  Geoffrey S Van Thiel; Keith R Berend; Gregg R Klein; Alexander C Gordon; Adolph V Lombardi; Craig J Della Valle
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

4.  The peel in total knee revision: exposure in the difficult knee.

Authors:  Carlos Lavernia; Juan Salvador Contreras; Jose Carlos Alcerro
Journal:  Clin Orthop Relat Res       Date:  2011-01       Impact factor: 4.176

5.  The use of spacers (static and mobile) in infection knee arthroplasty.

Authors:  Luca Mazzucchelli; Federica Rosso; Antongiulio Marmotti; Davide Edoardo Bonasia; Matteo Bruzzone; Roberto Rossi
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

6.  Are Frozen Sections and MSIS Criteria Reliable at the Time of Reimplantation of Two-stage Revision Arthroplasty?

Authors:  Jaiben George; Grzegorz Kwiecien; Alison K Klika; Deepak Ramanathan; Thomas W Bauer; Wael K Barsoum; Carlos A Higuera
Journal:  Clin Orthop Relat Res       Date:  2016-07       Impact factor: 4.176

7.  Sonication of antibiotic spacers predicts failure during two-stage revision for prosthetic knee and hip infections.

Authors:  Charles L Nelson; Robert B Jones; Nathaniel C Wingert; Michael Foltzer; Thomas R Bowen
Journal:  Clin Orthop Relat Res       Date:  2014-07       Impact factor: 4.176

8.  The results of two-stage revision TKA using Ceftazidime-Vancomycin-impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infections.

Authors:  Michael Drexler; Tim Dwyer; Paul R T Kuzyk; Yona Kosashvilli; Mansour Abolghasemian; Gilad J Regev; Assaf Kadar; Tal Frenkel Rutenberg; David Backstein
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-08-14       Impact factor: 4.342

9.  Assessing the gold standard: a review of 253 two-stage revisions for infected TKA.

Authors:  Tahir Mahmud; Matthew C Lyons; Douglas D Naudie; Steven J Macdonald; Richard W McCalden
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

10.  Prosthetic joint infections.

Authors:  Saima Aslam; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.